title: T-DM1 extravasation: first description.
authors: Department of Dermatology, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse, France.
authors: V
authors: http://orcid.org/0000-0003-2585-6633
authors: V
authors: Sibaud
authors: Department of Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse, France.
authors: S
authors: S
authors: Nougarolis
authors: Department of Dermatology, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse, France.
authors: C
authors: C
authors: Borjesson
authors: Department of Plastic Surgery, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse, France.
authors: D
authors: D
authors: Gangloff
authors: Department of Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse, France.
authors: J P
authors: JP
authors: Delord
authors: Department of Radiology, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse, France.
authors: V
authors: V
authors: Pompa
authors: Department of Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse, France.
authors: D
authors: D
authors: Saintenac
authors: Department of Oncology, Institut Claudius Regaud, Institut Universitaire du Cancer, Toulouse, France.
authors: H
authors: H
authors: Roche
mesh_terms: D000080044:Ado-Trastuzumab Emtansine; D000368:Aged; D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D005119:Extravasation of Diagnostic and Therapeutic Materials; D005260:Female; D006801:Humans; D008453:Maytansine / Q000008:administration & dosage / Q000031:analogs & derivatives*; D000068878:Trastuzumab
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D008453:Maytansine; D000068878:Trastuzumab; D000080044:Ado-Trastuzumab Emtansine